<?xml version="1.0" encoding="UTF-8"?>
<jcr:root xmlns:jcr="http://www.jcp.org/jcr/1.0" xmlns:nt="http://www.jcp.org/jcr/nt/1.0" xmlns:mix="http://www.jcp.org/jcr/mix/1.0" xmlns:cq="http://www.day.com/jcr/cq/1.0" xmlns:sling="http://sling.apache.org/jcr/sling/1.0"
    jcr:primaryType="cq:Page">
    <jcr:content
        cq:lastModified="{Date}2024-02-08T16:27:46.931Z"
        cq:lastModifiedBy="reference-adjustment-service"
        cq:template="/conf/menarini-berlinchemie/settings/wcm/templates/menarini---details-news"
        jcr:isCheckedOut="{Boolean}true"
        jcr:mixinTypes="[mix:versionable]"
        jcr:primaryType="cq:PageContent"
        jcr:title="Menarini announces an exclusive distribution agreement for Boditech’s AFIAS-10 system"
        jcr:uuid="c86fe21f-f03d-47ed-ba30-dbc34c7950e0"
        sling:resourceType="menarinimaster/components/page"
        dnnNewsIdentifier="8a1c191b-1720-40aa-88de-c68d8076ed34-2895">
        <root
            jcr:primaryType="nt:unstructured"
            sling:resourceType="menarinimaster/components/container"
            layout="responsiveGrid">
            <container
                jcr:primaryType="nt:unstructured"
                sling:resourceType="menarinimaster/components/container"
                layout="responsiveGrid">
                <internalheader
                    jcr:primaryType="nt:unstructured"
                    jcr:title="News &amp; Medien"
                    sling:resourceType="menarinimaster/components/internalheader"
                    altValueFromDAM="{Boolean}false"
                    imageFromPageImage="{Boolean}false"
                    titleFromPage="{Boolean}false"/>
                <section
                    jcr:lastModified="{Date}2023-05-23T15:09:53.441Z"
                    jcr:lastModifiedBy="a.messori@adiacent.com"
                    jcr:primaryType="nt:unstructured"
                    sling:resourceType="menarinimaster/components/section">
                    <wrapper
                        jcr:lastModified="{Date}2023-05-23T15:11:01.995Z"
                        jcr:lastModifiedBy="a.messori@adiacent.com"
                        jcr:primaryType="nt:unstructured"
                        sling:resourceType="menarinimaster/components/wrapper">
                        <breadcrumb
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/breadcrumb"/>
                    </wrapper>
                </section>
                <container
                    jcr:primaryType="nt:unstructured"
                    sling:resourceType="menarinimaster/components/container"
                    layout="responsiveGrid">
                    <internalmenu
                        jcr:primaryType="nt:unstructured"
                        sling:resourceType="menarinimaster/components/internalmenu"
                        navigationRoot="/content/menarini-berlinchemie/de/menarini-group-news"
                        structureStart="{Long}0">
                        <cq:responsive jcr:primaryType="nt:unstructured">
                            <default
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="3"/>
                            <tablet
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="4"/>
                            <phone
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="12"/>
                        </cq:responsive>
                    </internalmenu>
                    <container
                        cq:styleIds="[1684742346871]"
                        jcr:primaryType="nt:unstructured"
                        sling:resourceType="menarinimaster/components/container"
                        layout="responsiveGrid">
                        <news_data
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/news_data"
                            newsDate="{Date}2023-04-19T15:08:00.000Z">
                            <cq:responsive jcr:primaryType="nt:unstructured">
                                <default
                                    jcr:primaryType="nt:unstructured"
                                    offset="0"
                                    width="9"/>
                            </cq:responsive>
                        </news_data>
                        <title
                            cq:styleIds="[1653552493699]"
                            jcr:lastModified="{Date}2023-06-07T15:16:13.835Z"
                            jcr:lastModifiedBy="d.mariotti@adiacent.com"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/title"
                            linkTarget="_self"
                            type="h2"/>
                        <image
                            jcr:lastModified="{Long}1707398322412"
                            jcr:lastModifiedBy="Importer"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/image"
                            displayPopupTitle="true"
                            fileReference="/content/dam/menarini-berlinchemie/assets/news/thumbnailOK-800-450-p-L-97-800-450-p-L-97-1.jpg"
                            imageFromPageImage="{Boolean}false"
                            isDecorative="true"
                            linkTarget="_self"
                            titleValueFromDAM="false">
                            <cq:responsive jcr:primaryType="nt:unstructured">
                                <default
                                    jcr:primaryType="nt:unstructured"
                                    offset="2"
                                    width="4"/>
                                <phone
                                    jcr:primaryType="nt:unstructured"
                                    offset="1"
                                    width="10"/>
                            </cq:responsive>
                        </image>
                        <spacer
                            jcr:lastModified="{Date}2023-06-07T15:17:27.212Z"
                            jcr:lastModifiedBy="d.mariotti@adiacent.com"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/spacer"
                            spacer="40"/>
                        <text
                            jcr:lastModified="{Long}1707398322415"
                            jcr:lastModifiedBy="Importer"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/text"
                            text="&lt;p style=&quot;text-align: center;&quot;>&lt;img alt=&quot;&quot; src=&quot;/Portals/31/thumbnailOK-800-450-p-L-97-800-450-p-L-97%20%281%29.jpg&quot; style=&quot;width: 50%;&quot; title=&quot;&quot; />&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>The agreement covers the exclusive distribution of the AFIAS-10 Single Test Immuno-Assay System, including IGRA-Tuberculosis across 34 countries in Europe. &lt;/span>&lt;/strong>&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p style=&quot;margin-bottom:10px&quot;>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&amp;nbsp;&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>FLORENCE, ITALY, April&amp;nbsp;21 2023&lt;/span>&lt;/strong>, A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay (among others), building on several years of fruitful collaboration &amp;nbsp;with Boditech Med Inc. (Boditech) &amp;nbsp;in Italy. &lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>This agreement grants Menarini with immediate availability the exclusivity for the distribution - in 34 countries across Europe - of the integrated sample-to-answer system AFIAS-10, a fully automated diagnostic platform that can perform independently 10 different tests in parallel.&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>AFIAS-10 features an easy-to-use testing procedure directly from blood collection tubes with multi-testing performance that provides prompt results and allows the quick transmission of medical information. The all-in-one cartridge for the AFIAS platform is ready-to-use and contains all assay reagents. At present it is available for the measurement of over 50 parameters.&lt;/p>&#xa;&#xa;&lt;p>IGRA-TB is a cytokine release assay for quantitative determination of Interferon Gamma (IFN-γ) produced by human blood cells stimulated with Mycobacterium tuberculosis (MTB) antigens. In particular, the AFIAS IGRA-TB test is a simple, fast and cost-efficient fluorescent immuno-assay that can be used on the AFIAS-10 platform, an optimal latent tuberculosis testing solution for a large range of laboratories typology.&lt;/p>&#xa;&#xa;&lt;p>&lt;span lang=&quot;EN-US&quot; style=&quot;background:white&quot;>Tuberculosis is one of the leading causes of death&amp;nbsp;globally&lt;sup>1&lt;/sup>. According to WHO, an estimated 10.6 million people contracted tuberculosis worldwide and a total of 1.6 million people died from the disease in 2021&lt;sup>1&lt;/sup>. In Europe, an estimated 230,000 people fell ill with tuberculosis in 2021 and, for the first time in two decades, the incidence rate is estimated to have increased by 1.2% compared to 2020&lt;sup>2&lt;/sup>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span lang=&quot;EN-GB&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>Fabio Piazzalunga, Global Head of A. Menarini Diagnostics S.r.l., &lt;/span>&lt;/strong>stated: &lt;b>&amp;ldquo;&lt;/b>This agreement represents a great opportunity for our Company&lt;span lang=&quot;EN-GB&quot; style=&quot;background:white&quot;> to contribute to the required efficiency of IVD services&amp;nbsp; by&amp;nbsp; bringing &amp;nbsp;a highly innovative system for the immuno-assay single test market onto the&lt;/span> &lt;span style=&quot;background:white&quot;>EU market, being Afias-10 a perfect fit for decentralized use with cost effective positioning. The platform portfolio of assays includes tests with high&lt;/span> &lt;span style=&quot;background:white&quot;>medical value such as Latent Tuberculosis Testing. AFIAS-10 distribution will benefit from leveraging our strong&lt;/span> &lt;span style=&quot;background:white&quot;>sales and marketing forces deployed in the countries covered by the agreement&lt;/span>&amp;rdquo;.&lt;br />&#xa;&amp;nbsp;&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>For more information, please visit&lt;b> &lt;a href=&quot;https://www.menarinidiagnostics.com/en-us/Home/Professional-Diagnostics/Immunochemistry/AFIAS-10/Features&quot;>https://www.menarinidiagnostics.com/en-us/Home/Professional-Diagnostics/Immunochemistry/AFIAS-10/Features&lt;/a>&lt;/b>&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&amp;nbsp;&lt;/p>&#xa;&#xa;&lt;p>&lt;b>References&lt;/b>&lt;br />&#xa;1. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022.&lt;br />&#xa;2. European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2023 &amp;ndash; 2021 data.&lt;/p>&#xa;&#xa;&lt;p>&lt;br />&#xa;&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span lang=&quot;EN-GB&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>About Boditech Med&lt;/span>&lt;/strong>&lt;/span>&lt;/span>&lt;br />&#xa;Boditech Med Inc. has been developing products for in-vitro diagnostics and diagnostic reagents for the past 20 years. The company based in Korea has been leading the way in exploring new markets through the automation of on-site diagnosed immunodiagnostic devices and the development of new high-sensitive diagnostic.&lt;/p>&#xa;&#xa;&lt;p style=&quot;margin-bottom:10px&quot;>&amp;nbsp;&lt;/p>&#xa;&#xa;&lt;p>&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>About A.Menarini Diagnostics, the Human Touch of Technology&lt;/span>&lt;/strong>&lt;br />&#xa;For more than 45 years, the company has been dedicated to helping healthcare professionals make safe and sustainable diagnoses, improving the quality of life of people all over the world.&lt;br />&#xa;A.Menarini Diagnostics is part of the Menarini Pharmaceutical Group, founded in 1886. Today it is present in 140 countries throughout the world, with more than 17,000 employees and 2022 turnover of &amp;euro; 4.154 billion.&lt;br />&#xa;&lt;span style=&quot;background:white&quot;>For further information, please visit&lt;/span>:&amp;nbsp;&lt;a href=&quot;https://www.menarinidiagnostics.com/en-us/&quot;>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>www.menarinidiagnostics.com&lt;/span>&lt;/a> &lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm; text-underline:none&quot;>and &lt;/span>&lt;a href=&quot;https://www.linkedin.com/company/a.menarini-diagnostics-s.r.l./about/&quot;>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>Linkedin&lt;/span>&lt;/a>&lt;span lang=&quot;EN-US&quot; style=&quot;border:none windowtext 1.0pt; padding:0cm; text-underline:none&quot;>.&lt;/span>&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&lt;br />&#xa;&lt;span style=&quot;background:white&quot;>&lt;span style=&quot;vertical-align:baseline&quot;>&lt;strong>&lt;span style=&quot;border:none windowtext 1.0pt; padding:0cm&quot;>For media enquiries:&lt;/span>&lt;/strong>&lt;br />&#xa;Menarini Group, ufficiostampa@menarini.it, +39 055 56801 &amp;nbsp;&lt;/span>&lt;/span>&lt;/p>&#xa;&#xa;&lt;p>&amp;nbsp;&lt;/p>"
                            textIsRich="true"/>
                        <cq:responsive jcr:primaryType="nt:unstructured">
                            <default
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="8"/>
                            <tablet
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="8"/>
                            <phone
                                jcr:primaryType="nt:unstructured"
                                offset="0"
                                width="12"/>
                        </cq:responsive>
                    </container>
                </container>
            </container>
        </root>
        <cq:featuredimage
            jcr:primaryType="nt:unstructured"
            sling:resourceType="core/wcm/components/image/v3/image"
            altValueFromDAM="{Boolean}false"
            fileReference="/content/dam/menarini-berlinchemie/assets/news/thumbnailOK-800-450-p-L-97-800-450-p-L-97-1.jpg"/>
    </jcr:content>
</jcr:root>
